US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 46.520
  • -0.400-0.85%
Close Jan 17 16:00 ET
  • 46.520
  • 0.0000.00%
Post 20:01 ET
1.78BMarket Cap-12.41P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 62.911M--
--2024/Q4-- / 58.022M--
Nov 13, 20242024/Q348.118M / 43.177M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 62.911M--
--2024/Q4-- / 58.022M--
Nov 13, 20242024/Q348.118M / 43.177M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

  • Tarsus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:18 ET

  • Tarsus Pharmaceuticals | 8-K: Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

    Nov 13, 2024 16:12 ET

  • Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:21 ET

  • Tarsus Pharmaceuticals | 8-K: Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

    Aug 8, 2024 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 20, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data